Virtual reality startup and Fujitsu bring immersive drug design software to Japanese market

Advertisement

BEGIN ARTICLE PREVIEW:

SAN DIEGO, Sept. 14, 2020 /PRNewswire/ — San Diego–based virtual reality (VR) startup Nanome, Inc. has entered into an agreement with Fujitsu to bring their signature product—an immersive scientific design and collaboration platform—to the Japanese market. The software is already used by more than 15 of the top US-based biopharmaceutical companies. MoreNanome became the first VR software company to launch an immersive real-time collaboration platform for scientific discovery in 2015. The software environment accelerates scientific decision making by allowing users to visualize, modify, and simulate biological and chemical compounds, facilitating effective communication of data and integrating with existing computational chemistry workflows.”Our software enables the analysis of complicated structures in 3D space,” said Nanome COO Keita Funakawa. “It can help gain insights into data that were not accessible using 2D tools.”Beginning this month, Fujitsu, a multinational information technology equipment and services company headquartered in Tokyo, Japan, will sell Nanome software licenses to Japanese pharmaceutical companies. This places Nanome in one of the largest markets in the world. The startup hopes to expand the partnership to address the needs of chemical engineering and materials science companies.”The number of corporations in Japan using VR software is projected to more than double …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE